Invasive pulmonary aspergillosis was traditionally conceptualized as a rare infection restricted to profoundly immunocompromised patients. However, over the past decade, it's become increasingly clear that invasive aspergillosis can also occur as a nosocomial superinfection among patients who aren't immunocompromised (especially following influenza). This opens a can of worms regarding how to sift out colonization versus invasive infection, among critically ill patients who are usually unable to undergo tissue biopsy.
-
The IBCC chapter is located here.
- The podcast & comments are below.
Follow us on iTunes
The Podcast Episode
Want to Download the Episode?
Right Click Here and Choose Save-As
Josh is the creator of PulmCrit.org. He is an associate professor of Pulmonary and Critical Care Medicine at the University of Vermont.
Latest posts by Josh Farkas (see all)
- PulmCrit – I’m so confused about bamlanivimab - November 30, 2020
- PulmCrit – Oscar awards for the best COVID prognostic models - November 28, 2020
- PulmCrit – Heparin resistance in COVID & implications for DVT prophylaxis - November 24, 2020
Any place for serology in the diagnosis?
Hi, Thanks for sharing such an amazing post. It was very useful and informative as well!